Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("WOOTEN, G. Frederick")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 14 of 14

  • Page / 1
Export

Selection :

  • and

Preliminary fMRI evidence of visual system dysfunction in Parkinson's disease patients with visual hallucinationsHOLROYD, Suzanne; WOOTEN, G. Frederick.The Journal of neuropsychiatry and clinical neurosciences. 2006, Vol 18, Num 3, pp 402-404, issn 0895-0172, 3 p.Article

Amoxicillin-induced aseptic meningitisWITTMANN, Annemarei; WOOTEN, G. Frederick.Neurology. 2001, Vol 57, Num 9, issn 0028-3878, p. 1734Article

Diagnosis and initial management of Parkinson's diseaseNUTT, John G; WOOTEN, G. Frederick.The New England journal of medicine. 2005, Vol 353, Num 10, pp 1021-1027, issn 0028-4793, 7 p.Article

A novel deafness/dystonia peptide gene mutation that causes dystonia in female carriers of Mohr-Tranebjaerg syndromeSWERDLOW, Russell H; WOOTEN, G. Frederick.Annals of neurology. 2001, Vol 50, Num 4, pp 537-540, issn 0364-5134Article

Hypertrophic Olivary DegenerationKIMURA BRUNO, Michiko; WOOTEN, G. Frederick.Archives of neurology (Chicago). 2012, Vol 69, Num 2, pp 274-275, issn 0003-9942, 2 p.Article

Depression is associated with impairment of ADL, not motor function in Parkinson diseaseHOLROYD, Suzanne; CURRIE, Lillian J; WOOTEN, G. Frederick et al.Neurology. 2005, Vol 64, Num 12, pp 2134-2135, issn 0028-3878, 2 p.Article

Amphetamine-induced chorea in attention deficit-hyperactivity disorderMORGAN, John C; WINTER, W. Christopher; WOOTEN, G. Frederick et al.Movement disorders. 2004, Vol 19, Num 7, pp 840-842, issn 0885-3185, 3 p.Article

CENTRAL NERVOUS SYSTEM INVOLVEMENT IN AXONAL CHARCOT-MARIE-TOOTH DISEASEXINLI DU; WOOTEN, G. Frederick; MATSUMOTO, Julie A et al.Muscle & nerve. 2010, Vol 41, Num 1, pp 148-150, issn 0148-639X, 3 p.Article

Huntington CAG Repeat Size Does Not Modify Onset Age in Familial Parkinson's Disease : The GenePD StudyMCNICOLL, Christopher F; LATOURELLE, Jeanne C; WATTS, Ray L et al.Movement disorders. 2008, Vol 23, Num 11, pp 1596-1601, issn 0885-3185, 6 p.Article

Influence of heterozygosity for Parkin mutation on onset age in familial parkinson disease : The genepd studyMEI SUN; LATOURELLE, Jeanne C; PARSIAN, Abbas et al.Archives of neurology (Chicago). 2006, Vol 63, Num 6, pp 826-832, issn 0003-9942, 7 p.Article

UPDRS Activity of Daily Living Score as a Marker of Parkinson's Disease ProgressionHARRISON, Madaline B; WYLIE, Scott A; FRYSINGER, Robert C et al.Movement disorders. 2009, Vol 24, Num 2, pp 224-230, issn 0885-3185, 7 p.Article

G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophyOZELIUS, Laurie J; FOROUD, Tatiana; JANKOVIC, Joseph et al.Movement disorders. 2007, Vol 22, Num 4, pp 546-549, issn 0885-3185, 4 p.Article

Postmenopausal estrogen use affects risk for Parkinson diseaseCURRIE, Lillian J; HARRISON, Madaline B; TRUGMAN, Joel M et al.Archives of neurology (Chicago). 2004, Vol 61, Num 6, pp 886-888, issn 0003-9942, 3 p.Article

PARK3 influences age at onset in parkinson disease: A genome scan in the GenePD studyDESTEFANO, Anita L; LEW, Mark F; CURRIE, Lillian J et al.American journal of human genetics. 2002, Vol 70, Num 5, pp 1089-1095, issn 0002-9297Article

  • Page / 1